Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Development of a Novel Polyherbal Lip Hydrant for Improving Biophysical Barrier of the Lips
Authors not listed
Chulalongkorn University · 2024
Abstract
* The goal of this clinical trial is to evaluate the efficacy of the novel polyherbal lip hydrant on dryness, fine lines and color of the lips in 66Thai people aged between 18-40 years old. The inclusion criteria will include subjects with subjective complaint of dry lips.The main question it aims to answer is Does the novel polyherbal lip hydrant improve biophysical barrier of the lips?
* Participant will be asked to apply the lip hydrant or the petroleum gel once a day before bedtime, and refrain from using other lip products throughout the clinical trial period (28 days).
* Researchers will compare control group (Petroleum gel) with lip hydrant group to see whether biophysical barrier (wrinkles, colors, fine lines, roughness) improve or not.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Anonymous. (2024). Development of a Novel Polyherbal Lip Hydrant for Improving Biophysical Barrier of the Lips. <em>Chulalongkorn University</em>. https://clinicaltrials.gov/study/NCT06475482
Vancouver
Anonymous. Development of a Novel Polyherbal Lip Hydrant for Improving Biophysical Barrier of the Lips. Chulalongkorn University. 2024.
BibTeX
@misc{anon2024Develo,
title = {Development of a Novel Polyherbal Lip Hydrant for Improving Biophysical Barrier of the Lips},
author = {Anonymous},
journal = {Chulalongkorn University},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Death and Differentiation 2009
Open access · OA
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2021
Open access · US-GOV
Clinical Study on Immunogenicity and Safety of Recombinant Novel Coronavirus(COVID-19)Vaccine (CHO Cell) Combined With Tetravalent Influenza Virus Lysis Vaccine in People Aged 18 Years and Over
TS Biotech - Shandong Tiansheng Biotechnology Co., Ltd 2025
Open access · US-GOV
Evaluation of the Effects of a Dietary Supplement Containing a Full Range of Hyaluronic Acids in Healthy Female Subjects With Dry Facial Skin and Lips
Arbor Life Labs 2018
Open access · US-GOV
Hair Regrowth Efficacy of Multi-Molecular Targeting Treatment (ALRV5XR), a Randomized Controlled Clinical Trial in Women With Androgenetic Alopecia, Telogen Effluvium or Self Reported Thinning Hair: THE HAIR REBOOT TRIAL - WOMEN
Arbor Life Labs 2018
Open access · US-GOV
Hair Regrowth Efficacy of Multi-Molecular Targeting Treatment (ALRV5XR), a Randomized Controlled Clinical Trial in Men With Androgenetic Alopecia, Telogen Effluvium or Self Reported Thinning Hair: THE HAIR REBOOT TRIAL - MEN
Peking University People's Hospital 2026
Open access · US-GOV